Daclizumab and hepatitis c Patient Reports February 12, 2012



Daclizumab Side Effects Report #5124755-6
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4766444-3
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4766445-5
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection What is  cytomegalovirus infection, disease recurrence, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4792920-3
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4797110-6
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection What is  cytomegalovirus infection, disease recurrence, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4827477-1
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4848404-7
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cytomegalovirus infection What is  cytomegalovirus infection, disease recurrence, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with CELLCEPT, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4848405-9
Daclizumab side effect was reported by a Physician from FRANCE on Sept 07, 2005. Male patient, 65 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with CELLCEPT, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM, PARACETAMOL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #5442027-7
Daclizumab side effect was reported by a Physician from NETHERLANDS on Aug 24, 2007. Male patient, 54 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: bile duct stenosis, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #5303177-9
Daclizumab side effect was reported by a Physician from FRANCE on Apr 11, 2007. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: hepatic haematoma, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4564211-7
Daclizumab side effect was reported by a Physician from on Jan 17, 2005. Male patient, 41 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: hepatic haematoma, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CORTICOSTEROID NOS, TACROLIMUS. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4586483-5
Daclizumab side effect was reported by a Physician from on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: hepatic haematoma, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, TACROLIMUS, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4586892-4
Daclizumab side effect was reported by a Physician from on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatic haematoma, hepatitis a What is  hepatitis a, hepatitis c What is  hepatitis c. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, TACROLIMUS, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4601470-6
Daclizumab side effect was reported by a Physician from on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: complications of transplanted liver, hepatic haematoma, hepatitis c What is  hepatitis c, hypotension, insomnia. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, TACROLIMUS, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4690924-2
Daclizumab side effect was reported by a Physician from on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, gamma-glutamyltransferase decreased, hepatic haematoma, hepatic haemorrhage, hepatitis c What is  hepatitis c, hypotension, insomnia. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4917705-6
Daclizumab side effect was reported by a Physician from FRANCE on Jan 17, 2005. Male patient, 41 years of age, was diagnosed with prophylaxis and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: cholestasis, disease recurrence, hepatic haematoma, hepatitis c What is  hepatitis c, hypotension, insomnia, post procedural haemorrhage. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE, NEFOPAM. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Daclizumab